{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:20:33Z","timestamp":1790176833150,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000305","name":"National Eye Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000305","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Cardiff"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.neuroscience.2016.01.042","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T08:01:35Z","timestamp":1453708895000},"page":"92-106","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function"],"prefix":"10.1016","volume":"319","author":[{"given":"T.G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ganne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-9135","authenticated-orcid":false,"given":"M.","family":"Votruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.01.042_b0005","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bbadis.2012.07.002","article-title":"Defective mitochondrial fusion, altered respiratory function, and distorted cristae structure in skin fibroblasts with heterozygous OPA1 mutations","volume":"1822","author":"Agier","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0010","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/brain\/awm005","article-title":"A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy","volume":"130","author":"Alavi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-8-32","article-title":"Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics","volume":"8","author":"Alavi","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0025","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1167\/iovs.04-1340","article-title":"The Ins2Akita mouse as a model of early retinal complications in diabetes","volume":"46","author":"Barber","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0030","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b9000","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.exer.2011.07.004","article-title":"Specific deficits in visual electrophysiology in a mouse model of dominant optic atrophy","volume":"93","author":"Barnard","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0035","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/17425255.2010.530656","article-title":"Pharmacokinetic evaluation of idebenone","volume":"6","author":"Becker","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00228-008-0596-1","article-title":"Pharmacokinetics and metabolism of idebenone in healthy male subjects","volume":"65","author":"Bodmer","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0045","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S0140-6736(15)60025-3","article-title":"Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial","volume":"385","author":"Buyse","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0050","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2015.08.015","article-title":"OPA1-related disorders: diversity of clinical expression, modes of inheritance and pathophysiology","author":"Chao de la Barca","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0060","doi-asserted-by":"crossref","first-page":"e003012","DOI":"10.1161\/JAHA.112.003012","article-title":"OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability","volume":"1","author":"Chen","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.neuroscience.2016.01.042_b0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1499-3872(15)60425-8","article-title":"Liver expression of Nrf2-related genes in different liver diseases","volume":"14","author":"Cheng","year":"2015","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2006.02.079","article-title":"Morphological properties of mouse retinal ganglion cells","volume":"140","author":"Coombs","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.exer.2005.11.021","article-title":"Focus on molecules: the OPA1 protein","volume":"83","author":"Davies","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0080","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/ddm079","article-title":"Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function","volume":"16","author":"Davies","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0090","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1523\/JNEUROSCI.5461-12.2013","article-title":"Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma","volume":"33","author":"Della Santina","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0095","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.64.6.803","article-title":"Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia","volume":"64","author":"Di Prospero","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/3.6.977","article-title":"Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis","volume":"3","author":"Eiberg","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0105","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1523\/JNEUROSCI.1419-14.2015","article-title":"Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types","volume":"35","author":"El-Danaf","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1101\/gr.108696.110","article-title":"OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution","volume":"21","author":"Elachouri","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0115","doi-asserted-by":"crossref","first-page":"e36153","DOI":"10.1371\/journal.pone.0036153","article-title":"Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I","volume":"7","author":"Erb","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/abbi.1996.0267","article-title":"The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria","volume":"330","author":"Esposti","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2013.07.002","article-title":"The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse","volume":"262","author":"Fiebiger","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2015.02.047","article-title":"Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene","volume":"351","author":"Formichi","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jneumeth.2014.01.016","article-title":"A new mathematical function to evaluate neuronal morphology using the Sholl analysis","volume":"226","author":"Garcia-Segura","year":"2014","journal-title":"J Neurosci Methods"},{"issue":"12","key":"10.1016\/j.neuroscience.2016.01.042_b0140","doi-asserted-by":"crossref","first-page":"e81114","DOI":"10.1371\/journal.pone.0081114","article-title":"The mouse age phenome knowledgebase and disease-specific inter-species age mapping","volume":"8","author":"Geifman","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbabio.2011.10.012","article-title":"The effects of idebenone on mitochondrial bioenergetics","volume":"1817","author":"Giorgio","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exer.2014.02.023","article-title":"Recharging mitochondrial batteries in old eyes. Near infra-red increases ATP","volume":"122","author":"Gkotsi","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0155","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2015.01.009","article-title":"Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10","volume":"4","author":"Gueven","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0160","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0165","doi-asserted-by":"crossref","first-page":"e45182","DOI":"10.1371\/journal.pone.0045182","article-title":"Idebenone protects against retinal damage and loss of vision in a mouse model of Leber\u2019s hereditary optic neuropathy","volume":"7","author":"Heitz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0170","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/PL00005296","article-title":"Idebenone protects hippocampal neurons against amyloid beta-peptide-induced neurotoxicity in rat primary cultures","volume":"358","author":"Hirai","year":"1998","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2016.01.042_b0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","article-title":"Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?","volume":"47","author":"Jaber","year":"2015","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0180","doi-asserted-by":"crossref","first-page":"e67989","DOI":"10.1371\/journal.pone.0067989","article-title":"Presynaptic localization and possible function of calcium-activated chloride channel anoctamin 1 in the mammalian retina","volume":"8","author":"Jeon","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0185","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1021\/bi802282h","article-title":"Reduction of hydrophilic ubiquinones by the flavin in mitochondrial NADH:ubiquinone oxidoreductase (Complex I) and production of reactive oxygen species","volume":"48","author":"King","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0190","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2016.01.042_b0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00415-009-1006-z","article-title":"Pharmacokinetic properties and metabolism of idebenone","volume":"256","author":"Kutz","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nutres.2006.06.017","article-title":"Dietary phytic acid lowers the blood glucose level in diabetic KK mice","volume":"26","author":"Lee","year":"2006","journal-title":"Nutr Res"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0210","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1167\/iovs.14-13892","article-title":"Differential protection of injured retinal ganglion cell dendrites by brimonidine","volume":"56","author":"Lindsey","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0215","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.neurobiolaging.2014.12.021","article-title":"Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol","volume":"36","author":"Lindsey","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0014-4886(90)90005-D","article-title":"Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins","volume":"108","author":"Miyamoto","year":"1990","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0225","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","article-title":"Hereditary optic neuropathies","volume":"18","author":"Newman","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0230","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jcp.20950","article-title":"Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis","volume":"211","author":"Olichon","year":"2007","journal-title":"J Cell Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2016.01.042_b0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.12322","article-title":"Co-enzyme Q10 and idebenone use in Friedreich\u2019s ataxia","volume":"126","author":"Parkinson","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0240","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.15252\/embj.201488349","article-title":"OPA1-dependent cristae modulation is essential for cellular adaptation to metabolic demand","volume":"33","author":"Patten","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0245","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/cvr\/cvs117","article-title":"Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload","volume":"94","author":"Piquereau","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.neuroscience.2016.01.042_b0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/WNO.0b013e3182745600","article-title":"Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model","volume":"32","author":"Porciatti","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0255","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/emboj.2012.70","article-title":"Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice","volume":"31","author":"Quiros","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0260","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/brain\/aws303","article-title":"The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse","volume":"135","author":"Sarzi","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0265","doi-asserted-by":"crossref","first-page":"e0133656","DOI":"10.1371\/journal.pone.0133656","article-title":"Inhibition of ANO1\/TMEM16A chloride channel by idebenone and its cytotoxicity to cancer cell lines","volume":"10","author":"Seo","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0270","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/hmg\/ddh114","article-title":"Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia","volume":"13","author":"Seznec","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0275","first-page":"387","article-title":"Dendritic organization in the neurons of the visual and motor cortices of the cat","volume":"87","author":"Sholl","year":"1953","journal-title":"J Anat"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0280","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1083\/jcb.200704110","article-title":"OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L","volume":"178","author":"Song","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1254\/jjp.35.196","article-title":"Inhibition of lipid peroxidation by a novel compound, idebenone (CV-2619)","volume":"35","author":"Suno","year":"1984","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0290","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.cmet.2015.05.007","article-title":"The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage","volume":"21","author":"Varanita","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0295","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","article-title":"Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy","volume":"116","author":"Votruba","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0300","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.35.10.793","article-title":"Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy","volume":"35","author":"Votruba","year":"1998","journal-title":"J Med Genet"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0305","doi-asserted-by":"crossref","first-page":"29521","DOI":"10.1074\/jbc.M004128200","article-title":"Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site","volume":"275","author":"Walter","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0310","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/brain\/awq218","article-title":"Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy","volume":"133","author":"Williams","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0315","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/awr330","article-title":"Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity","volume":"135","author":"Williams","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0320","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI11103","article-title":"Overexpression of 6-phosphofructo-2-kinase\/fructose-2, 6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose production","volume":"107","author":"Wu","year":"2001","journal-title":"J Clin Investig"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0325","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0330","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.2014.37","article-title":"Treatment strategies for inherited optic neuropathies: past, present and future","volume":"28","author":"Yu-Wai-Man","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0335","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.042_b0340","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1091\/mbc.E10-12-0933","article-title":"The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP production in pancreatic beta cells","volume":"22","author":"Zhang","year":"2011","journal-title":"Mol Biol Cell"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:56:47Z","timestamp":1589626607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":69,"alternative-id":["S0306452216000701"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.042","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}